类器官模型在癌症精准医疗中的应用。
Organoid modeling for cancer precision medicine.
机构信息
Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA 94305 USA.
出版信息
Genome Med. 2015 Mar 31;7(1):32. doi: 10.1186/s13073-015-0158-y. eCollection 2015.
Abstract
Three-dimensional organotypic culture models show great promise as a tool for cancer precision medicine, with potential applications for oncogene modeling, gene discovery and chemosensitivity studies.
摘要
三维器官型培养模型作为癌症精准医疗的工具具有很大的潜力，可应用于癌基因建模、基因发现和化疗敏感性研究。
相似文献
1
Organoid modeling for cancer precision medicine.类器官模型在癌症精准医疗中的应用。
Genome Med. 2015 Mar 31;7(1):32. doi: 10.1186/s13073-015-0158-y. eCollection 2015.
2
Automation of Organoid Cultures: Current Protocols and Applications.类器官培养的自动化：当前方案和应用。
SLAS Discov. 2021 Oct;26(9):1138-1147. doi: 10.1177/24725552211024547. Epub 2021 Jun 24.
3
Tumor organoids: applications in cancer modeling and potentials in precision medicine.肿瘤类器官：在癌症建模中的应用及精准医学中的潜力
J Hematol Oncol. 2022 May 12;15(1):58. doi: 10.1186/s13045-022-01278-4.
4
Application of organoid culture from HPV18-positive small cell carcinoma of the uterine cervix for precision medicine.HPV18 阳性宫颈小细胞癌类器官培养在精准医学中的应用。
Cancer Med. 2023 Apr;12(7):8476-8489. doi: 10.1002/cam4.5588. Epub 2023 Jan 23.
5
The power and the promise of organoid models for cancer precision medicine with next-generation functional diagnostics and pharmaceutical exploitation.类器官模型在癌症精准医学中借助下一代功能诊断和药物开发所具有的力量与前景。
Transl Oncol. 2021 Aug;14(8):101126. doi: 10.1016/j.tranon.2021.101126. Epub 2021 May 18.
6
Progress and perspective of organoid technology in cancer-related translational medicine.类器官技术在癌症相关转化医学中的进展与展望
Biomed Pharmacother. 2022 May;149:112869. doi: 10.1016/j.biopha.2022.112869. Epub 2022 Mar 28.
8
Organoid Models of Heart Diseases: Find a New Channel in Improvements of Cardiac Regenerative Medicine.心脏病类器官模型：为心脏再生医学的改善找到新途径。
Curr Med Chem. 2023;30(33):2726-3742. doi: 10.2174/0929867330666221021122603.
9
Organoid engineering with microfluidics and biomaterials for liver, lung disease, and cancer modeling.微流控与生物材料的类器官工程用于肝脏、肺部疾病和癌症建模。
Acta Biomater. 2021 Sep 15;132:37-51. doi: 10.1016/j.actbio.2021.03.002. Epub 2021 Mar 9.
10
Single-Cell and Spatial Analysis of Emergent Organoid Platforms.单细胞和新兴类器官平台的空间分析。
Methods Mol Biol. 2023;2660:311-344. doi: 10.1007/978-1-0716-3163-8_22.
引用本文的文献
1
Generation and Maintenance of Patient-Derived Endometrial Cancer Organoids.患者来源的子宫内膜癌类器官的生成与维持。
Bio Protoc. 2024 Oct 20;14(20):e5093. doi: 10.21769/BioProtoc.5093.
2
3D cell culture models in research: applications to lung cancer pharmacology.研究中的3D细胞培养模型：在肺癌药理学中的应用
Front Pharmacol. 2024 Sep 23;15:1438067. doi: 10.3389/fphar.2024.1438067. eCollection 2024.
3
Organoids in recapitulating tumorigenesis driven by risk factors: Current trends and future perspectives.类器官在重现风险因素驱动的肿瘤发生中的作用：当前趋势和未来展望。
Int J Biol Sci. 2022 Mar 28;18(7):2729-2743. doi: 10.7150/ijbs.70406. eCollection 2022.
4
Harnessing the predictive power of preclinical models for oncology drug development.利用临床前模型预测肿瘤药物开发的潜力。
Nat Rev Drug Discov. 2022 Feb;21(2):99-114. doi: 10.1038/s41573-021-00301-6. Epub 2021 Oct 26.
5
High-resolution positron emission microscopy of patient-derived tumor organoids.高分辨率正电子发射显微镜对患者来源的肿瘤类器官进行成像。
Nat Commun. 2021 Oct 7;12(1):5883. doi: 10.1038/s41467-021-26081-6.
6
Tumor Chemosensitivity Assays Are Helpful for Personalized Cytotoxic Treatments in Cancer Patients.肿瘤化疗敏感性检测有助于癌症患者的个体化细胞毒治疗。
Medicina (Kaunas). 2021 Jun 19;57(6):636. doi: 10.3390/medicina57060636.
7
Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids.厄洛替尼耐药亚群在患者来源的肺肿瘤球体和类器官中重现。
PLoS One. 2020 Sep 8;15(9):e0238862. doi: 10.1371/journal.pone.0238862. eCollection 2020.
8
Microfluidic methods for precision diagnostics in food allergy.用于食物过敏精准诊断的微流控方法。
Biomicrofluidics. 2020 Apr 3;14(2):021503. doi: 10.1063/1.5144135. eCollection 2020 Mar.
9
Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.个性化医疗——结直肠癌当前及新出现的预测和预后生物标志物
Cancers (Basel). 2020 Mar 28;12(4):812. doi: 10.3390/cancers12040812.
10
Establishment of patient-derived three-dimensional organoid culture in renal cell carcinoma.建立肾细胞癌患者来源的三维类器官培养。
Investig Clin Urol. 2020 Mar;61(2):216-223. doi: 10.4111/icu.2020.61.2.216. Epub 2020 Feb 3.
本文引用的文献
1
Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.使用 CRISPR-Cas9 介导的人类肠道类器官工程技术构建结直肠癌模型。
Nat Med. 2015 Mar;21(3):256-62. doi: 10.1038/nm.3802. Epub 2015 Feb 23.
2
Organoid models of human and mouse ductal pancreatic cancer.人类和小鼠胰腺导管癌的类器官模型
Cell. 2015 Jan 15;160(1-2):324-38. doi: 10.1016/j.cell.2014.12.021. Epub 2014 Dec 31.
3
Patient-derived models of acquired resistance can identify effective drug combinations for cancer.患者来源的获得性耐药模型可识别出针对癌症的有效联合用药方案。
Science. 2014 Dec 19;346(6216):1480-6. doi: 10.1126/science.1254721. Epub 2014 Nov 13.
4
Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.转移性肿瘤演变和类器官建模表明，转化生长因子β受体2（TGFBR2）是弥漫性胃癌的癌症驱动因素。
Genome Biol. 2014 Aug 27;15(8):428. doi: 10.1186/s13059-014-0428-9.
5
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture.原代类器官培养中多种胃肠道组织的致癌转化。
Nat Med. 2014 Jul;20(7):769-77. doi: 10.1038/nm.3585. Epub 2014 May 25.
6
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer.全基因组测序和全面分子谱分析鉴定胃癌中的新驱动突变。
Nat Genet. 2014 Jun;46(6):573-82. doi: 10.1038/ng.2983. Epub 2014 May 11.
7
Genetic reconstitution of tumorigenesis in primary intestinal cells.在原代肠道细胞中重建肿瘤发生的遗传机制。
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11127-32. doi: 10.1073/pnas.1221926110. Epub 2013 Jun 17.
8
Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications.从单个肠干细胞中培育自组织的微型肠道：机制与应用。
Science. 2013 Jun 7;340(6137):1190-4. doi: 10.1126/science.1234852.
9
Generating human intestinal tissue from pluripotent stem cells in vitro.体外多能干细胞生成人类肠道组织。
Nat Protoc. 2011 Nov 10;6(12):1920-8. doi: 10.1038/nprot.2011.410.
10
Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor.人角质形成细胞可被 Rho 激酶抑制剂有效地永生化。
J Clin Invest. 2010 Jul;120(7):2619-26. doi: 10.1172/JCI42297.
Zotero 插件